Océanie · Actualité · The Advertiser (Adelaide Now)

Long Shortz Optiscan: FDA submission opens path to US commercialisation

Publié par The Advertiser (Adelaide Now) · Australie il y a 15 h

CEO and Managing Director Dr Camile Farah to discuss the company’s US FDA 510(k) submission for its InForm digital pathology device, a major milestone towards potential US…

Lire l'article complet sur The Advertiser (Adelaide Now) Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.adelaidenow.com.au)

Long Shortz Optiscan: FDA submission opens path to US commercialisation

À lire aussi

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

‘Left with no choice’: Jetstar workers to strike at major airports ahead of Grand Final weekend

View from The Hill: how far will the opposition go on industrial relations reform? Probably not too far

First home buyers with big loans among those most at risk of falling into negative equity, RBA warns

Long Shortz Optiscan: FDA submission opens path to US commercialisation

Partager

À lire aussi

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

‘Left with no choice’: Jetstar workers to strike at major airports ahead of Grand Final weekend

View from The Hill: how far will the opposition go on industrial relations reform? Probably not too far

First home buyers with big loans among those most at risk of falling into negative equity, RBA warns